Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?
ثبت نشده
چکیده
Current epidemiological data from the USA, Europe, Asia and the Indian subcontinent, Africa, the Far East, South America, the Middle East and Eastern Europe all point to the increasing incidence of renal failure encompassing acute kidney injury (AKI), chronic kidney disease (CKD) and endstage renal disease (ESRD). While the explanations for these worldwide epidemics remain speculative, it must be acknowledged that these increases in AKI, CKD and ESRD, happening worldwide, have occurred despite the universal application of strategies of renoprotection over the last 2 decades, more especially the widespread use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). We note that many of the published large renin-angiotensin-aldosterone system (RAAS) blockPublished online: March 7, 2011 Macaulay Onuigbo, MD, MSc, FWACP, FASN Department of Nephrology, Midelfort Clinic Mayo Health System, 1221 Whipple Street Eau Claire, WI 54702 (USA) Tel. +1 715 838 3891, E-Mail onuigbo.macaulay @ mayo.edu © 2011 S. Karger AG, Basel 1660–2110/11/1184–0407$38.00/0 Accessible online at: www.karger.com/nec D ow nl oa de d by : 54 .7 0. 40 .1 1 11 /5 /2 01 7 7: 12 :1 9 P M Onuigbo Nephron Clin Pract 2011;118:c407–c419 c408 Introduction – The Renal Failure Epidemic around
منابع مشابه
Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases
Following the skyrocketing spread of SARS-CoV-2 into almost all the countries over five continents, diverse clinical strategies are urgently needed to defeat its pandemic, considering that an magic-bullet antiviral vaccine or treatment is presently unavailable. WHO later proclaimed the viral outbreak as a pandemic. Despite this fast speed of the pandemic, any recommended treatment must first...
متن کاملCan ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?
Current epidemiological data from the USA, Europe, Asia and the Indian subcontinent, Africa, the Far East, South America, the Middle East and Eastern Europe all point to the increasing incidence of renal failure encompassing acute kidney injury (AKI), chronic kidney disease (CKD) and endstage renal disease (ESRD). While the explanations for these worldwide epidemics remain speculative, it must ...
متن کاملCombination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
Dual blockade of the renin-angiotensin system (RAS) with a combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the treatment of hypertension and proteinuria has been tested in several randomized trials among patients with chronic kidney disease (CKD). Although combination therapy reduces proteinuria and blood pressure, adequately powered studies evaluat...
متن کاملIn-Depth Review Mineralocorticoid Receptor Blockers and Chronic Kidney Disease
The increasing prevalence of chronic kidney disease (CKD) and the public health initiatives for detection and slowing its progression have placed special emphasis on controlling proteinuria and the renin-angiotensin-aldosterone system (RAAS). In addition to the traditional blockers of angiotensin-converting enzyme and angiotensin receptors, mineralocorticoid receptor blockers (MRBs) have come i...
متن کاملRenoprotection with antihypertensive effect by inhibition of rennin - angiotensin system
Hypertension is a common cause of chronic kidney disease (CKD) and even more common sequelae of CKD. It is essential to preserve renal function while controlling blood pressure. There is growing evidence that reduction and normalization of proteinuria is a key treatment goal for renal protection. Several clinical studies, mainly but not exclusively in diabetic patients were reviewed, subsequent...
متن کامل